Joe E Mouawad
Overview
Explore the profile of Joe E Mouawad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adewale A, Sharma S, Mouawad J, Nguyen X, Bradshaw A, Feghali-Bostwick C
Matrix Biol
. 2024 Jun;
132:24-33.
PMID: 38852924
Pulmonary fibrosis (PF) is a clinically severe and commonly fatal complication of Systemic Sclerosis (SSc). Our group has previously reported profibrotic roles for Insulin-like Growth Factor II (IGF-II) and Lysyl...
2.
Mouawad J, Feghali-Bostwick C
Arthritis Rheumatol
. 2023 Aug;
76(1):149.
PMID: 37605520
No abstract available.
3.
Mouawad J, Sanderson M, Sharma S, Helke K, Pilewski J, Nadig S, et al.
Arthritis Rheumatol
. 2023 Jun;
75(12):2228-2239.
PMID: 37390364
Objectives: Systemic sclerosis (SSc) has the highest mortality rate among the rheumatic diseases, with lung fibrosis leading as the cause of death. A characteristic of severe SSc-related lung fibrosis is...
4.
Mouawad J, Feghali-Bostwick C
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769282
Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disorder that affects the connective tissues and has the highest mortality rate among the rheumatic diseases. One of the hallmarks...
5.
Mouawad J, Heywood J, Armstrong M, Ogunleye A, Feghali-Bostwick C
Plast Reconstr Surg Glob Open
. 2022 Nov;
10(11):e4626.
PMID: 36389611
Methods: An ex vivo model of skin fibrosis was used with abdominal and breast skin tissue from 45 patients undergoing breast reduction and/or abdominoplasty. Fibrosis was induced in skin explants...
6.
Mouawad J, Sharma S, Renaud L, Pilewski J, Nadig S, Feghali-Bostwick C
Rheumatology (Oxford)
. 2022 Jul;
62(3):1306-1316.
PMID: 35900152
Objectives: Lung fibrosis is the leading cause of death in SSc, with no cure currently available. Antifibrotic Endostatin (ES) production does not reach therapeutic levels in SSc patients, suggesting a...
7.
Ghayad S, Rammal G, Sarkis O, Basma H, Ghamloush F, Fahs A, et al.
Cancer Biol Ther
. 2018 Oct;
20(3):272-283.
PMID: 30307360
Rhabdomyosarcoma (RMS) is an aggressive childhood sarcoma with two distinct subtypes, embryonal (ERMS) and alveolar (ARMS) histologies. More effective treatment is needed to improve outcomes, beyond conventional cytotoxic chemotherapy. The...